Reynders Mc Veigh Capital Management, LLC Gsk PLC Transaction History

Reynders Mc Veigh Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$40.23 - $47.74 $272,759 - $323,677	-6,780 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$38.88 - $45.31 $263,606 - $307,201	6,780 New	6,780 $299,000
Q4 2020 Feb 10, 2021	SELL	$34.07 - $39.94 $238,455 - $279,540	-6,999 Closed	0 $0
Q3 2020 Oct 28, 2020	SELL	$38.11 - $42.99 $334,834 - $377,710	-8,786 Reduced 55.66%	6,999 $263,000
Q2 2020 Aug 14, 2020	BUY	$37.87 - $43.58 $597,777 - $687,910	15,785 New	15,785 $644,000
Q1 2018 May 03, 2018	SELL	$36.18 - $40.15 $315,091 - $349,666	-8,709 Closed	0 $0
Q4 2017 Feb 06, 2018	SELL	$35.34 - $41.9 $132,525 - $157,125	-3,750 Reduced 30.1%	8,709 $0
Q3 2017 Nov 09, 2017	SELL	$39.44 - $41.55 $15,776 - $16,620	-400 Reduced 3.11%	12,459 $506,000
Q2 2017 Aug 14, 2017	BUY	N/A	12,859	12,859 $554,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Reynders Mc Veigh Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Reynders Mc Veigh Capital Management, LLC with notifications on news.